{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:47:58Z","timestamp":1791946078781,"version":"4.3.4"},"reference-count":96,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073456"],"award-info":[{"award-number":["82073456"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173421"],"award-info":[{"award-number":["82173421"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["23ZR1408600"],"award-info":[{"award-number":["23ZR1408600"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Sailing Program","award":["21YF1404400"],"award-info":[{"award-number":["21YF1404400"]}]},{"name":"Clinical Research Plan of SHDC","award":["SHDC22022302"],"award-info":[{"award-number":["SHDC22022302"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Vitiligo is an autoimmune skin disease that targets pigment-producing melanocytes and results in depigmentation. This disfiguring condition frequently affects visible areas of the body and therefore causes a heavy psychological burden and a decreased quality of life. Although it remains intractable, the ever-growing understanding of its immunopathogenesis has dramatically shaped the treatment paradigm for vitiligo. With the impact of autoreactive cytotoxic T cells explained extensively, accumulating evidence suggests the unique role of regulatory T cells (Tregs) in the immune microenvironment of vitiligo. We systematically reviewed Treg deficiency, instability, reduced vitality and dysfunction in people with vitiligo, combined with novel findings regarding Treg function modulation in autoimmune backgrounds, including metabolic alteration, post-translational modifications and interaction with other immune cells. We further summarized classic and advanced Treg-targeted therapeutics in vitiligo practice and research. Herein, we share up-to-date knowledge of Tregs in vitiligo, providing insights into novel Treg-based therapeutic strategies.<\/jats:p>","DOI":"10.1093\/bjd\/ljae472","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T22:00:40Z","timestamp":1734213640000},"page":"796-806","source":"Crossref","is-referenced-by-count":12,"title":["Emerging role of regulatory T cells in the immunopathogenesis of vitiligo and implications for treatment"],"prefix":"10.1093","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1573-2038","authenticated-orcid":false,"given":"Yang","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Immunology, Shanghai Jiao Tong University , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanxuan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2712-3962","authenticated-orcid":false,"given":"Leihong","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Immunology, Shanghai Jiao Tong University , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,14]]},"reference":[{"key":"2025042813573231600_ljae472-B1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"2025042813573231600_ljae472-B2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/med.21754","article-title":"Mechanisms of melanocyte death in vitiligo","volume":"41","author":"Chen","year":"2021","journal-title":"Med Res Rev"},{"key":"2025042813573231600_ljae472-B3","doi-asserted-by":"crossref","first-page":"6952299","DOI":"10.1155\/2022\/6952299","article-title":"Meta-analysis of alterations in regulatory T cells\u2019 frequency and suppressive capacity in patients with vitiligo","volume":"2022","author":"Giri","year":"2022","journal-title":"J Immunol Res"},{"key":"2025042813573231600_ljae472-B4","doi-asserted-by":"crossref","first-page":"e37513","DOI":"10.1371\/journal.pone.0037513","article-title":"Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo","volume":"7","author":"Lili","year":"2012","journal-title":"PLOS ONE"},{"key":"2025042813573231600_ljae472-B5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"2025042813573231600_ljae472-B6","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1172\/JCI72932","article-title":"Memory regulatory T cells reside in human skin","volume":"124","author":"Sanchez Rodriguez","year":"2014","journal-title":"J Clin Invest"},{"key":"2025042813573231600_ljae472-B7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3389\/fimmu.2018.00883","article-title":"Emerging functions of regulatory T cells in tissue homeostasis","volume":"9","author":"Sharma","year":"2018","journal-title":"Front Immunol"},{"key":"2025042813573231600_ljae472-B8","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1084\/jem.20072594","article-title":"Foxp3+ regulatory T cells maintain immune homeostasis in the skin","volume":"205","author":"Dudda","year":"2008","journal-title":"J Exp Med"},{"key":"2025042813573231600_ljae472-B9","doi-asserted-by":"crossref","first-page":"eadh0152","DOI":"10.1126\/sciimmunol.adh0152","article-title":"Regulatory T cells in skin mediate immune privilege of the hair follicle stem cell niche","volume":"9","author":"Cohen","year":"2024","journal-title":"Sci Immunol"},{"key":"2025042813573231600_ljae472-B10","first-page":"550","article-title":"Cytotoxic T lymphocyte reactivity to gp100, melanA\/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients","volume":"2003","author":"Mandelcorn-Monson","journal-title":"J Invest Dermatol"},{"key":"2025042813573231600_ljae472-B11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/bjd.14416","article-title":"Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Dermatol"},{"key":"2025042813573231600_ljae472-B12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaci.2016.10.013","article-title":"Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes","volume":"140","author":"Li","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2025042813573231600_ljae472-B13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jid.2016.09.016","article-title":"Keratinocyte-derived chemokines orchestrate T-cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease","volume":"137","author":"Richmond","year":"2017","journal-title":"J Invest Dermatol"},{"key":"2025042813573231600_ljae472-B14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2025042813573231600_ljae472-B15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat Med"},{"key":"2025042813573231600_ljae472-B16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"2025042813573231600_ljae472-B17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jid.2017.08.038","article-title":"Vitiligo skin is imprinted with resident memory CD8\u2005T cells expressing CXCR3","volume":"138","author":"Boniface","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2025042813573231600_ljae472-B18","doi-asserted-by":"crossref","first-page":"eaam7710","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci Transl Med"},{"key":"2025042813573231600_ljae472-B19","doi-asserted-by":"crossref","first-page":"e14982","DOI":"10.1111\/exd.14982","article-title":"Compromised melanocyte survival due to decreased suppression of CD4+ & CD8+ resident memory T cells by impaired TRM-regulatory T cells in generalized vitiligo patients","volume":"33","author":"Shah","year":"2024","journal-title":"Exp Dermatol"},{"key":"2025042813573231600_ljae472-B20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/exd.12183","article-title":"A central role for inducible heat-shock protein 70 in autoimmune vitiligo","volume":"22","author":"Mosenson","year":"2013","journal-title":"Exp Dermatol"},{"key":"2025042813573231600_ljae472-B21","doi-asserted-by":"crossref","first-page":"10113","DOI":"10.1073\/pnas.0711106105","article-title":"Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation","volume":"105","author":"Onishi","year":"2008","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"key":"2025042813573231600_ljae472-B22","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/ni1003","article-title":"Modulation of tryptophan catabolism by regulatory T cells","volume":"4","author":"Fallarino","year":"2003","journal-title":"Nat Immunol"},{"key":"2025042813573231600_ljae472-B23","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.4049\/jimmunol.180.9.5916","article-title":"Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II","volume":"180","author":"Liang","year":"2008","journal-title":"J Immunol"},{"key":"2025042813573231600_ljae472-B24","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat Commun"},{"key":"2025042813573231600_ljae472-B25","doi-asserted-by":"crossref","first-page":"110737","DOI":"10.1016\/j.humimm.2023.110737","article-title":"Altered regulatory T cell-mediated Natural Killer cells suppression may lead to generalized vitiligo","volume":"85","author":"Giri","year":"2024","journal-title":"Hum Immunol"},{"key":"2025042813573231600_ljae472-B26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/pcmr.12862","article-title":"Altered expression of nuclear factor of activated T cells, forkhead box P3, and immune-suppressive genes in regulatory T cells of generalized vitiligo patients","volume":"33","author":"Giri","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"key":"2025042813573231600_ljae472-B27","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/pcmr.12105","article-title":"Decreased regulatory T-cells and CD4+\/CD8+ ratio correlate with disease onset and progression in patients with generalized vitiligo","volume":"26","author":"Dwivedi","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"2025042813573231600_ljae472-B28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/ijd.13564","article-title":"Regulatory T-cell cytokines in patients with nonsegmental vitiligo","volume":"56","author":"Kidir","year":"2017","journal-title":"Int J Dermatol"},{"key":"2025042813573231600_ljae472-B29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00403-019-01996-9","article-title":"Predominant role of innate pro-inflammatory cytokines in vitiligo disease","volume":"312","author":"Gholijani","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"2025042813573231600_ljae472-B30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2013.05.005","article-title":"T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo","volume":"424","author":"Tembhre","year":"2013","journal-title":"Clin Chim Acta"},{"key":"2025042813573231600_ljae472-B31","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/jid.2015.26","article-title":"CCL22 to activate Treg migration and suppress depigmentation in vitiligo","volume":"135","author":"Eby","year":"2015","journal-title":"J Invest Dermatol"},{"key":"2025042813573231600_ljae472-B32","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jid.2022.05.1090","article-title":"Regulatory T cells require CCR6 for skin migration and local suppression of vitiligo","volume":"142","author":"Essien","year":"2022","journal-title":"J Invest Dermatol"},{"key":"2025042813573231600_ljae472-B33","doi-asserted-by":"crossref","first-page":"eabd8995","DOI":"10.1126\/scitranslmed.abd8995","article-title":"scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in Treg function","volume":"13","author":"Gellatly","year":"2021","journal-title":"Sci Transl Med"},{"key":"2025042813573231600_ljae472-B34","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41577-023-00893-7","article-title":"The role of transcription factors in shaping regulatory T cell identity","volume":"23","author":"Trujillo-Ochoa","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"2025042813573231600_ljae472-B35","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.3389\/fimmu.2019.02486","article-title":"Foxp3 post-translational modifications and Treg suppressive activity","volume":"10","author":"Deng","year":"2019","journal-title":"Front Immunol"},{"key":"2025042813573231600_ljae472-B36","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/exd.14157","article-title":"Decreased suppression of CD8+ and CD4+ T cells by peripheral regulatory T cells in generalized vitiligo due to reduced NFATC1 and FOXP3 proteins","volume":"29","author":"Giri","year":"2020","journal-title":"Exp Dermatol"},{"key":"2025042813573231600_ljae472-B37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/bjd.12377","article-title":"Association between FOXP3 polymorphisms and vitiligo in a Han Chinese population","volume":"169","author":"Song","year":"2013","journal-title":"Br J Dermatol"},{"key":"2025042813573231600_ljae472-B38","doi-asserted-by":"crossref","first-page":"147629","DOI":"10.1016\/j.gene.2023.147629","article-title":"Genetic association of nuclear factor of activated T cells\u2019 3\u2019UTR and structural polymorphisms with susceptibility to generalized vitiligo in Gujarat population","volume":"880","author":"Giri","year":"2023","journal-title":"Gene"},{"key":"2025042813573231600_ljae472-B39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"2025042813573231600_ljae472-B40","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1053\/j.gastro.2011.03.009","article-title":"Interleukin-12 converts Foxp3+ regulatory T cells to interferon-\u03b3-producing Foxp3+ T cells that inhibit colitis","volume":"140","author":"Feng","year":"2011","journal-title":"Gastroenterology"},{"key":"2025042813573231600_ljae472-B41","doi-asserted-by":"crossref","first-page":"102859","DOI":"10.1016\/j.jaut.2022.102859","article-title":"Th1-like Treg in vitiligo: an incompetent regulator in immune tolerance","volume":"131","author":"Chen","year":"2022","journal-title":"J Autoimmun"},{"key":"2025042813573231600_ljae472-B42","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41590-020-0674-9","article-title":"Type 1 Treg cells promote the generation of CD8+ tissue-resident memory T cells","volume":"21","author":"Ferreira","year":"2020","journal-title":"Nat Immunol"},{"key":"2025042813573231600_ljae472-B43","doi-asserted-by":"crossref","first-page":"1055958","DOI":"10.3389\/fimmu.2022.1055958","article-title":"Immunometabolism in the pathogenesis of vitiligo","volume":"13","author":"Lyu","year":"2022","journal-title":"Front Immunol"},{"key":"2025042813573231600_ljae472-B44","doi-asserted-by":"crossref","first-page":"8820","DOI":"10.3390\/ijms22168820","article-title":"Metabolic comorbidities in vitiligo: a brief review and report of new data from a single-center experience","volume":"22","author":"D\u2019Arino","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025042813573231600_ljae472-B45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s42255-022-00575-z","article-title":"Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics","volume":"4","author":"Liu","year":"2022","journal-title":"Nat Metab"},{"key":"2025042813573231600_ljae472-B46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00403-005-0565-9","article-title":"Narrowband-UVB irradiation decreases the production of pro-\u00adinflammatory cytokines by stimulated T cells","volume":"297","author":"Sigmundsdottir","year":"2005","journal-title":"Arch Dermatol Res"},{"key":"2025042813573231600_ljae472-B47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdermsci.2019.01.003","article-title":"The impact of irradiance on UVB-induced cutaneous immunosuppression: implications on administering most efficient phototherapy","volume":"93","author":"Lai","year":"2019","journal-title":"J Dermatol Sci"},{"key":"2025042813573231600_ljae472-B48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/exd.12369","article-title":"T helper 17 and Tregs: a novel proposed mechanism for NB-UVB in vitiligo","volume":"23","author":"Hegazy","year":"2014","journal-title":"Exp Dermatol"},{"key":"2025042813573231600_ljae472-B49","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.molmed.2024.04.009","article-title":"Vitiligo: advances in pathophysiology research and treatment development","volume":"30","author":"Mukhatayev","year":"2024","journal-title":"Trends Mol Med"},{"key":"2025042813573231600_ljae472-B50","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.immuni.2020.07.002","article-title":"Anti-inflammatory roles of glucocorticoids are mediated by Foxp3+ regulatory T cells via a miR-342-dependent mechanism","volume":"53","author":"Kim","year":"2020","journal-title":"Immunity"},{"key":"2025042813573231600_ljae472-B51","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1073\/pnas.89.9.3686","article-title":"Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A","volume":"89","author":"Fruman","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025042813573231600_ljae472-B52","doi-asserted-by":"crossref","first-page":"790125","DOI":"10.3389\/fimmu.2021.790125","article-title":"Janus kinase inhibitors in the treatment of vitiligo: a review","volume":"12","author":"Qi","year":"2021","journal-title":"Front Immunol"},{"key":"2025042813573231600_ljae472-B53","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa2118828","article-title":"Two phase 3, randomized, controlled trials of ruxolitinib cream for vitiligo","volume":"387","author":"Rosmarin","year":"2022","journal-title":"N Engl J Med"},{"key":"2025042813573231600_ljae472-B54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/phpp.12241","article-title":"Low 25-hydroxyvitamin D levels are associated with vitiligo: a systematic review and meta-analysis","volume":"32","author":"Upala","year":"2016","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2025042813573231600_ljae472-B55","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.3390\/ijms24054689","article-title":"How does vitamin D affect immune cells crosstalk in autoimmune diseases?","volume":"24","author":"Gallo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025042813573231600_ljae472-B56","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.4049\/jimmunol.0803217","article-title":"1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3","volume":"183","author":"Jeffery","year":"2009","journal-title":"J Immunol"},{"key":"2025042813573231600_ljae472-B57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.autrev.2012.07.007","article-title":"Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature","volume":"12","author":"Antico","year":"2012","journal-title":"Autoimmun Rev"},{"key":"2025042813573231600_ljae472-B58","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41584-021-00707-x","article-title":"Interleukin-2 and regulatory T cells in rheumatic diseases","volume":"17","author":"Kolios","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2025042813573231600_ljae472-B59","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41577-022-00680-w","article-title":"Engineering IL-2 for immunotherapy of autoimmunity and cancer","volume":"22","author":"Hernandez","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"2025042813573231600_ljae472-B60","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3390\/cells12121671","article-title":"The PI3K-Akt-mTOR and associated signaling pathways as molecular drivers of immune-mediated inflammatory skin diseases: update on therapeutic strategy using natural and synthetic compounds","volume":"12","author":"Roy","year":"2023","journal-title":"Cells"},{"key":"2025042813573231600_ljae472-B61","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7150\/ijbs.17318","article-title":"Novel approaches to vitiligo treatment via modulation of mTOR and NF-\u03baB pathways in human skin melanocytes","volume":"13","author":"Wan","year":"2017","journal-title":"Int J Biol Sci"},{"key":"2025042813573231600_ljae472-B62","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/jid.2013.540","article-title":"A quantitative increase in regulatory T cells controls development of vitiligo","volume":"134","author":"Chatterjee","year":"2014","journal-title":"J Invest Dermatol"},{"key":"2025042813573231600_ljae472-B63","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1080\/21645515.2021.1872342","article-title":"Polymeric nanoparticles containing rapamycin and autoantigen induce antigen-specific immunological tolerance for preventing vitiligo in mice","volume":"17","author":"Zhang","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"2025042813573231600_ljae472-B64","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/jdv.19022","article-title":"The possible role of Wnt\/\u03b2-catenin signalling in vitiligo treatment","volume":"37","author":"Lin","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025042813573231600_ljae472-B65","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nm1707","article-title":"Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells","volume":"14","author":"Ding","year":"2008","journal-title":"Nat Med"},{"key":"2025042813573231600_ljae472-B66","first-page":"303","article-title":"Wnt signaling in dendritic cells: its role in regulation of immunity and tolerance","volume":"19","author":"Swafford","year":"2015","journal-title":"Discov Med"},{"key":"2025042813573231600_ljae472-B67","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1038\/jid.2015.372","article-title":"Melanocyte regeneration in vitiligo requires WNT beneath their wings","volume":"135","author":"Harris","year":"2015","journal-title":"J Invest Dermatol"},{"key":"2025042813573231600_ljae472-B68","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1083\/jcb.200311122","article-title":"Mesenchymal\u2013epithelial interactions in the skin: increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation","volume":"165","author":"Yamaguchi","year":"2004","journal-title":"J Cell Biol"},{"key":"2025042813573231600_ljae472-B69","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3389\/fimmu.2017.01360","article-title":"Indoleamine 2,3-dioxygenase and tolerance: where are we now?","volume":"8","author":"Mellor","year":"2017","journal-title":"Front Immunol"},{"key":"2025042813573231600_ljae472-B70","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1182\/blood-2008-12-195354","article-title":"Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes","volume":"113","author":"Sharma","year":"2009","journal-title":"Blood"},{"key":"2025042813573231600_ljae472-B71","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3390\/ijms22031104","article-title":"A new insight into the potential role of tryptophan-derived AhR ligands in skin physiological and pathological processes","volume":"22","author":"Szelest","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025042813573231600_ljae472-B72","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2023.04.006","article-title":"Modulation of T cells by tryptophan metabolites in the kynurenine pathway","volume":"44","author":"Stone","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"2025042813573231600_ljae472-B73","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/jid.2010.269","article-title":"The aryl hydrocarbon receptor mediates UVB radiation-induced skin tanning","volume":"131","author":"Jux","year":"2011","journal-title":"J Invest Dermatol"},{"key":"2025042813573231600_ljae472-B74","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1136\/annrheumdis-2013-203756","article-title":"The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells","volume":"73","author":"Kubo","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025042813573231600_ljae472-B75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdermsci.2006.08.004","article-title":"Macrophage-derived chemokine (MDC)\/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis","volume":"44","author":"Hashimoto","year":"2006","journal-title":"J Dermatol Sci"},{"key":"2025042813573231600_ljae472-B76","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/bjd.13511","article-title":"Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation","volume":"172","author":"Tembhre","year":"2015","journal-title":"Br J Dermatol"},{"key":"2025042813573231600_ljae472-B77","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jisp.2016.10.023","article-title":"Replenishing regulatory T cells to halt depigmentation in vitiligo","volume":"18","author":"Le Poole","year":"2017","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2025042813573231600_ljae472-B78","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jaad.2020.03.132","article-title":"Immune checkpoint inhibitor-related dermatologic adverse events","volume":"83","author":"Geisler","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025042813573231600_ljae472-B79","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa2008250","article-title":"Trial of upadacitinib or abatacept in rheumatoid arthritis","volume":"383","author":"Rubbert-Roth","year":"2020","journal-title":"N Engl J Med"},{"key":"2025042813573231600_ljae472-B80","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1200\/JCO.20.01086","article-title":"Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD","volume":"39","author":"Watkins","year":"2021","journal-title":"J Clin Oncol"},{"key":"2025042813573231600_ljae472-B81","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-19407-w","article-title":"PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin","volume":"8","author":"Miao","year":"2018","journal-title":"Sci Rep"},{"key":"2025042813573231600_ljae472-B82","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/exd.13952","article-title":"Expression analysis of PD-1 and Tim-3 immune checkpoint receptors in patients with vitiligo; positive association with disease activity","volume":"28","author":"Rahimi","year":"2019","journal-title":"Exp Dermatol"},{"key":"2025042813573231600_ljae472-B83","doi-asserted-by":"crossref","first-page":"579022","DOI":"10.3389\/fimmu.2020.579022","article-title":"Targeting the PD-1\/PD-L1 axis in human vitiligo","volume":"11","author":"Willemsen","year":"2020","journal-title":"Front Immunol"},{"key":"2025042813573231600_ljae472-B84","doi-asserted-by":"crossref","first-page":"1166135","DOI":"10.3389\/fimmu.2023.1166135","article-title":"Opportunities for Treg cell therapy for the treatment of human disease","volume":"14","author":"Bluestone","year":"2023","journal-title":"Front Immunol"},{"key":"2025042813573231600_ljae472-B85","doi-asserted-by":"crossref","first-page":"581433","DOI":"10.3389\/fimmu.2020.581433","article-title":"Antigen specificity enhances disease control by Tregs in vitiligo","volume":"11","author":"Mukhatayev","year":"2020","journal-title":"Front Immunol"},{"key":"2025042813573231600_ljae472-B86","doi-asserted-by":"crossref","first-page":"102761","DOI":"10.1016\/j.autrev.2021.102761","article-title":"Engineered antigen-specific regulatory T cells for autoimmune skin conditions","volume":"20","author":"Mukhatayev","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2025042813573231600_ljae472-B87","doi-asserted-by":"crossref","first-page":"e1423\u20135","DOI":"10.1111\/jdv.19347","article-title":"Combination of NB-UVB phototherapy and oral vitamin D supplementation in patients with generalized vitiligo: a randomized, triple-blind, placebo-controlled clinical trial","volume":"37","author":"Garza-Davila","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025042813573231600_ljae472-B88","doi-asserted-by":"crossref","first-page":"e14886","DOI":"10.1111\/dth.14886","article-title":"Efficacy of the combined excimer light and topical calcipotriol for acral vitiligo: a randomized double-blind comparative study","volume":"34","author":"Juntongjin","year":"2021","journal-title":"Dermatol Ther"},{"key":"2025042813573231600_ljae472-B89","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jdv.12726","article-title":"Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial","volume":"29","author":"Khullar","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025042813573231600_ljae472-B90","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/dth.12289","article-title":"Monochromatic excimer light versus combination of topical steroid with vitamin D3 analogue in the treatment of nonsegmental vitiligo: a randomized blinded comparative study","volume":"28","author":"Abdel Latif","year":"2015","journal-title":"Dermatol Ther"},{"key":"2025042813573231600_ljae472-B91","first-page":"e37180","article-title":"Apremilast add-on benefits over conventional drugs (ABCD) in unstable non-segmental vitiligo: a 12-week single-center randomized controlled trial","volume":"15","author":"Sharma","year":"2023","journal-title":"Cureus"},{"key":"2025042813573231600_ljae472-B92","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jaad.2020.12.073","article-title":"Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI: a randomized split-body pilot study","volume":"85","author":"Kim","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2025042813573231600_ljae472-B93","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jid.2019.11.031","article-title":"Apremilast in combination with narrowband UVB in the treatment of vitiligo: a 52-week monocentric prospective randomized placebo-controlled study","volume":"140","author":"Khemis","year":"2020","journal-title":"J Invest Dermatol"},{"key":"2025042813573231600_ljae472-B94","doi-asserted-by":"crossref","first-page":"e12923","DOI":"10.1111\/dth.12923","article-title":"Apremilast is effective in controlling the progression of adult vitiligo: a case series","volume":"32","author":"Majid","year":"2019","journal-title":"Dermatol Ther"},{"key":"2025042813573231600_ljae472-B95","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jaad.2020.01.035","article-title":"Afamelanotide implants and narrow-band ultraviolet B phototherapy for the treatment of nonsegmental vitiligo in Asians","volume":"82","author":"Toh","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025042813573231600_ljae472-B96","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jamadermatol.2014.4951","article-title":"Indications and limitations of afamelanotide for treating vitiligo \u2013 reply","volume":"151","author":"Lim","year":"2015","journal-title":"JAMA Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljae472\/61182954\/ljae472.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/192\/5\/796\/61182954\/ljae472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/192\/5\/796\/61182954\/ljae472.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T17:57:52Z","timestamp":1745863072000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/192\/5\/796\/7924149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,14]]},"references-count":96,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,12,14]]},"published-print":{"date-parts":[[2025,4,28]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljae472","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,12,14]]}}}